Literature DB >> 9354646

Expression and mutagenesis of mammalian cytosolic NADP+-specific isocitrate dehydrogenase.

G T Jennings1, K I Minard, L McAlister-Henn.   

Abstract

Rat liver cytosolic NADP+-specific isocitrate dehydrogenase (IDP2) was expressed in bacteria as a fusion protein with maltose binding protein (MBP). High levels of expression were obtained. The fusion protein was purified from bacterial lysates by affinity chromatography with an amylose resin and found to be catalytically active. IDP2 was separated from MBP by cleavage with protease Xa and purified to homogeneity by FPLC anion-exchange chromatography. A specific activity of 56.3 units/mg and respective apparent Km values for dl-isocitrate and NADP+ of 9.7 +/- 2.9 microM and 11.5 +/- 0.2 microM were obtained for the purified enzyme. These values are similar to those previously reported for cytosolic isocitrate dehydrogenase isolated from a variety of tissues. Evolutionarily conserved arginine residues implicated in substrate binding were changed to glutamate residues using PCR based site-directed mutagenesis of the bacterial fusion plasmid. Mutant enzymes containing residue changes of R100E, R109E, R119E, or R132E were expressed, purified, and characterized by initial rate kinetic analyses. The R119E and R109E mutant enzymes exhibited respective 15- and 31-fold increases in Km values for dl-isocitrate relative to the wild-type enzyme. In contrast, Km values for NADP+ were, respectively, unchanged and increased 9-fold. The most significant reductions in kcat/Km values were obtained for the R100E, R109E, and R132E enzymes. These results suggest that substrate binding residues are highly conserved between bacterial and mammalian enzymes despite low overall homology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354646     DOI: 10.1021/bi970916r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Towards a general model for protein-substrate stereoselectivity.

Authors:  Vidyasankar Sundaresan; Ravinder Abrol
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

2.  Identification and functional characterization of isocitrate dehydrogenase 1 (IDH1) mutations in thyroid cancer.

Authors:  Avaniyapuram Kannan Murugan; Ermal Bojdani; Mingzhao Xing
Journal:  Biochem Biophys Res Commun       Date:  2010-02-18       Impact factor: 3.575

3.  Prognostic value of IDH1 mutations identified with PCR-RFLP assay in glioblastoma patients.

Authors:  Mateusz Bujko; Paulina Kober; Ewa Matyja; Paweł Nauman; Katarzyna Dyttus-Cebulok; Beata Czeremszyńska; Wiesław Bonicki; Janusz A Siedlecki
Journal:  Mol Diagn Ther       Date:  2010-06-01       Impact factor: 4.074

4.  Dual compartmental localization and function of mammalian NADP+-specific isocitrate dehydrogenase in yeast.

Authors:  Qian Lu; Karyl I Minard; Lee McAlister-Henn
Journal:  Arch Biochem Biophys       Date:  2008-02-06       Impact factor: 4.013

5.  Biochemical characterization of NADP⁺-dependent isocitrate dehydrogenase from Microcystis aeruginosa PCC7806.

Authors:  Ming-Ming Jin; Peng Wang; Xue Li; Xiao-Yu Zhao; Lei Xu; Ping Song; Guo-Ping Zhu
Journal:  Mol Biol Rep       Date:  2012-12-22       Impact factor: 2.316

6.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

Review 7.  Emerging metabolic targets in cancer therapy.

Authors:  Yuhua Zhao; Hao Liu; Adam I Riker; Oystein Fodstad; Susan P Ledoux; Glenn L Wilson; Ming Tan
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

Review 8.  Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.

Authors:  Zachary J Reitman; Hai Yan
Journal:  J Natl Cancer Inst       Date:  2010-05-31       Impact factor: 11.816

9.  IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.

Authors:  Koichi Ichimura; Danita M Pearson; Sylvia Kocialkowski; L Magnus Bäcklund; Raymond Chan; David T W Jones; V Peter Collins
Journal:  Neuro Oncol       Date:  2009-05-12       Impact factor: 12.300

10.  IDH1 and IDH2 mutations in gliomas.

Authors:  Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.